Biochemical premotor biomarkers for Parkinson's disease

被引：28

作者：

Mollenhauer, Brit ^{[1
,2
]}

Zhang, Jing ^{[3
]}

机构：

[1] Paracelsus Elena Klin, D-34128 Kassel, Germany

[2] Univ Gottingen, Kassel, Germany

[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA

来源：

MOVEMENT DISORDERS | 2012年 / 27卷 / 05期

关键词：

biomarkers; genomics; metabolomics; Parkinson's disease; premotor; proteomics; HUMAN CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; GENE-EXPRESSION; URIC-ACID; ALZHEIMER; PROTEIN; URATE; DJ-1; CSF; PROTEOMICS;

D O I：

10.1002/mds.24956

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathologic processes or of pharmacologic responses to a therapeutic intervention. We reviewed the current status of target protein biomarkers (eg, total/oligomeric a-synuclein and DJ-1) in cerebrospinal fluid, as well as on unbiased processes that can be used to discover novel biomarkers. We have also provide ddetails about strategies toward potential populations/models and technologies, including the need for standardized sampling techniques, to pursue the identification of new biochemical markers in the premotor stage of Parkinson's disease in the future. (C) 2012 Movement Disorder Society

引用

页码：644 / 650

页数：7

共 50 条

[31] Biomarkers for Parkinson's disease
Graeber, Manuel B.
EXPERIMENTAL NEUROLOGY, 2009, 216 (02) : 249 - 253
[32] Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program
Gwinn, Katrina
David, Karen K.
Swanson-Fischer, Christine
Albin, Roger
St Hillaire-Clarke, Coryse
Sieber, Beth-Anne
Lungu, Codrin
Bowman, F. DuBois
Alcalay, Roy N.
Babcock, Debra
Dawson, Ted M.
Dewey, Richard B., Jr.
Foroud, Tatiana
German, Dwight
Huang, Xuemei
Petyuk, Vlad
Potashkin, Judith A.
Saunders-Pullman, Rachel
Sutherland, Margaret
Walt, David R.
West, Andrew B.
Zhang, Jing
Chen-Plotkin, Alice
Scherzer, Clemens R.
Vaillancourt, David E.
Rosenthal, Liana S.
BIOMARKERS IN MEDICINE, 2017, 11 (06) : 451 - 473
[33] Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Sierra, Maria
Sanchez-Juan, Pascual
Isabel Martinez-Rodriguez, Maria
Gonzalez-Aramburu, Isabel
Garica-Gorostiaga, Ines
Remedios Quirce, Maria
Palacio, Enrique
Manuel Carril, Jose
Berciano, Jose
Combarros, Onofre
Infante, Jon
NEUROLOGY, 2013, 80 (07) : 621 - 626
[34] Executive dysfunctions: A premotor biomarker of familial Parkinson's disease?
Kwiatkowski, A.
Dujardin, K.
Delliaux, M.
Duhamel, A.
Decroix, P.
Steinling, M.
Defebvre, L.
Destee, A.
MOVEMENT DISORDERS, 2010, 25 (07) : S320 - S320
[35] Cognitive and premotor planning of writing acitivities in Parkinson's disease
Buescher, C
Vogt, T
Dieterich, M
JOURNAL OF NEUROLOGY, 2004, 251 : 19 - 19
[36] Effect of neupro on premotor and nonmotor symptoms in Parkinson's disease
Isaacson, S. H.
Ailincai, M. L.
Kreitzman, D. L.
MOVEMENT DISORDERS, 2008, 23 (01) : S334 - S334
[37] Cardiovascular physiology in premotor Parkinson's disease: A neuroepidemiologic study
Jain, Samay
Ton, Thanh G.
Perera, Subashan
Zheng, Yan
Stein, Phyllis K.
Thacker, Evan
Strotmeyer, Elsa S.
Newman, Anne B.
Longstreth, Will T., Jr.
MOVEMENT DISORDERS, 2012, 27 (08) : 988 - 995
[38] Interactions between the premotor and motor cortices in Parkinson's disease
Castillo, G.
Kuriakose, R.
Udupa, K.
Yeh, I. -J.
Elahi, B.
Saha, U.
Gunraj, C.
Ni, Z.
Chen, R.
MOVEMENT DISORDERS, 2008, 23 (01) : S232 - S232
[39] Parkinson's disease risk score: moving to a premotor diagnosis
Winkler, Juergen
Ehret, Reinhard
Buettner, Thomas
Dillmann, Ulrich
Fogel, Wolfgang
Sabolek, Michael
Winkelmann, Juliane
Kassubek, Jan
JOURNAL OF NEUROLOGY, 2011, 258 : S311 - S315
[40] SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease
Booij, Jan
Knol, Remco J. J.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S425 - S428

← 1 2 3 4 5 →